Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arcadia Biosciences, Inc.RKDA · Entity 8593 | Director · 10% owner | June 07, 2017 | June 09, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arcadia Biosciences, Inc.
Report date June 07, 2017 · Filed June 09, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.73 · Expires 2027-06-07 | Direct | 60,350 |
Reported balance
After 2017-06-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-07 · Grant · Acquired 60,350 · Balance 60,350 F1: The Option will become 100% vested and excercisable on the earlier to occur of (i) June 7, 2018 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Particpant's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: The Option will become 100% vested and excercisable on the earlier to occur of (i) June 7, 2018 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Particpant's continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2017 Filed Jun 9, 2017 17:24 UTC | Arcadia Biosciences, Inc. RKDA · Entity 8593 | GrantStock Option (right to buy) · Derivative | 60,350 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001209191-17-038936 · doc4.xml · derivative · entry 1 Garg Uday · CIK 0001641250 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,350 Underlying: Common Stock · 60,350 shares Expires 2027-06-07 F1 · derivative.exercise_date: The Option will become 100% vested and excercisable on the earlier to occur of (i) June 7, 2018 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Particpant's continued service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.